AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00397930 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Yoga Intervention (YOCAS)
Description: The Yoga for Cancer Survivors (YOCAS) intervention uses two forms of yoga: Gentle Hatha yoga and Restorative yoga. The YOCAS sessions are standardized, and each session includes physical alignment postures, breathing and mindfulness exercises. The intervention is delivered in an instructor taught, group format, twice a week for 75 minutes each time over 4 weeks for a total of eight sessions of yoga. All sessions were taught in community-based sites (eg. yoga studios, community centers, community oncology practices) with an average group size of 12 (range, 10-15) in the late afternoon or evening after 4pm.
Study NCT03363438 — intervention group
Intervention type: OTHER
Intervention: no intervention survey
Description: there was no intervention this was a survey
Study NCT01975584 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test
Description: Participants will participate in a standardized role play (Trier Social Stress Test ). A role play is pretending to be in a certain situation. A research staff member will describe the role play, during which teh participant will act out a scene. Participants will be asked to imagine that they are in a certain role with several other research team members who will also participate in the role play. Participants will also be asked to do some math problems without using paper or pencil.
Study NCT03730896 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Dryneedling of the sternocleidomastoid muscles within a standard treatment approach of physical therapy
Study NCT05025228 — intervention group
Intervention type: DRUG
Intervention: Paracetamol
Description: Paracetamol given orally or intravenously
Study NCT01718795 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bag-valve mask or laryngeal tube ventilation
Description: Interventions are either Bag-valve mask (BVM) or Laryngeal tube (LT) ventilation during CPR
Study NCT00056589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: catridecacog
Description: Single doses of rFXIII administered intravenously (IV) to two subjects in each of the five dose levels (2, 6, 20, 50 and 75 U/kg).
Study NCT00990457 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weight Loss Diets Plus Exercise
Description: The weight loss diet will be either a low-carbohydrate diet or a low-fat, low-calorie diet. All participants will also be enrolled in a supervised exercise program.~The supervised exercise training sessions will take place three times a week for 6 months. Each session will last 1 to 1 ½ hours and will include aerobic exercise and weight training.
Study NCT01881490 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRE
Description: Developing the Pediatric Crohn's Disease Intestinal Damage Score (pMEDIC score) and the Pediatric MRE-Based Activity Index (PICMI)
Study NCT03403335 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Practices for Health Care Professionals in Training
Description: Eight weekly sessions including didactic lecture, discussion, homework, gentle yoga, and meditation and mindfulness exercises
Study NCT00474981 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IMNCI
Description: Implementation of IMNCI in the intervention sites
Study NCT01187680 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spraygel
Study NCT01187680 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Good surgical technique, no adhesion barrier
Study NCT03464370 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Measure of emotional stressors
Description: For the Epileptic Group~* Rapid interrogation, completing the clinical data~* A scale of impact of the precipitating factors of crises~* An emotional Stroop~* A task of detecting emotional targets against threatening information~* A measure of the perception of emotions using film clips~* A scale of measurement of perceived stress~* The transfer of psychiatric scales~For the healthy volunteers group :~* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality~* An emotional Stroop~* A task of detecting emotional targets against threatening information~* A scale of measurement of perceived stress~* A measure of the perception of emotions using film clips~* A rapid neuropsychological assessment
Study NCT03464370 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measure of emotional stressors
Description: For the Epileptic Group~* Rapid interrogation, completing the clinical data~* A scale of impact of the precipitating factors of crises~* An emotional Stroop~* A task of detecting emotional targets against threatening information~* A measure of the perception of emotions using film clips~* A scale of measurement of perceived stress~* The transfer of psychiatric scales~For the healthy volunteers group :~* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality~* An emotional Stroop~* A task of detecting emotional targets against threatening information~* A scale of measurement of perceived stress~* A measure of the perception of emotions using film clips~* A rapid neuropsychological assessment
Study NCT02206581 — intervention group
Intervention type: DEVICE
Intervention: Hydration Monitor
Study NCT04476589 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Functional MRI
Description: measurement of functional brain networks
Study NCT02965287 — intervention group
Intervention type: OTHER
Intervention: Serum metabolomics profiling
Description: The serum samples will be used to get a metabolomic profile
Study NCT03488758 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CMF
Description: Taking a infant formula based on cow milk protein fractions, 4-5 feeds per day given by bottle, 180-210 ml/feed, total 800-900ml per day for one mounth
Study NCT03488758 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GMF
Description: Taking a infant formula based on whole goat milk, 4-5 feeds per day given by bottle, 180-210 ml/feed, total 800-900ml per day for one mounth
Study NCT01766661 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hand-sewn coloanal anastomosis
Description: After low anterior rectal resection due to low rectal neoplasm patients undergo intestinal reconstructions as hand-sewn coloanal anastomosis with protective loop ileostomy.
Study NCT01766661 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Two staged Turnbull-Cutait procedure
Description: After low anterior rectal resection due to low rectal neoplasm patients undergo intestinal reconstructions as two staged Turnbull-Cutait procedure anastomosis without protective ileostomy.
Study NCT01766661 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultralow anterior rectal resection with total mesorectal excision
Description: Standard ultralow anterior rectal resection with total mesorectal excision
Study NCT01766661 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultralow anterior rectal resection with total mesorectal excision
Description: Standard ultralow anterior rectal resection with total mesorectal excision
Study NCT01564446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Participants will receive a internet based secure message confirming adherence to post-discharge medication regimen
Description: Participants will receive a internet based secure message via My HealtheVet (MHV), The VA's online medical record and secure messaging portal. The message will specify post-discharge prescribed medications and inquire about adherence to these medications.
Study NCT01931072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Description: Interval training 3 times a week for 8 weeks
Study NCT01931072 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Moderate training
Description: Moderate training 3 times a week for 8 weeks
Study NCT00335192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patients in treatment with 3TC + TDF + LPV/rtv, stop tenofovir during 4 weeks
Description: 3TC (300 mg/24 h, 1 tablet/24 h) + Lopinavir/ritonavir (400 mg/12 h, 3 tablets/12 h)
Study NCT03489291 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: AAV5-hFIXco-Padua (AMT-061)
Description: Single intravenous infusion of AAV5-hFIXco-Padua (AMT-061)
Study NCT00335192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patients in treatment with ABV + TDF + LPV/rtv, stop tenofovir during 4 weeks
Description: ABV (300 mg/12 h, 1 tablet/12 h)+ Lopinavir/ritonavir (400 mg/12 h, 3 tablets/12 h)
Study NCT00335192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patients in treatment with 3TC + ABV + TDF+ LPV/rtv, stop TDF during 4 weeks
Description: 3TC (300 mg/24 h, 1 tablet/24 h)+ ABV (300 mg/12 h, 1 tablet/12 h)+ Lopinavir/ritonavir (400 mg/12 h, 3 tablets/12 h).
Study NCT02296801 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole
Study NCT02296801 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Study NCT02296801 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Letrozole
Study NCT02296801 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palbociclib
Study NCT02296801 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: palbociclib
Study NCT04294849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: A. Phosphorous 31 MR Spectroscopy to evaluate skeletal muscle metabolism via measurement of depletion and recovery of phosphocreatine (PCr) B. Non-invasive arterial spin labeling MRI to evaluate lymphatic flow velocities and venous flow
Study NCT04294849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bicycle Ergometry
Description: To measure peak VO2 as a representation of global aerobic fitness
Study NCT04294849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lab Panel
Description: A. Inflammatory lab panel (IL-6, IL-8, TNF alpha, P-selectin, high sensitivity CRP, IL-6 receptor, TNF R1/R2) drawn at diagnosis B. Thrombin Generation Assay to measure hypercoagulability and Thromboelastography prior to initiating anticoagulation
Study NCT04294849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: A. Dalhousie Dyspnea Scale B. Godin Leisure Time Exercise Questionnaire C. Pediatric Venous Quality of Life Questionnaire
Study NCT01619449 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Renal replacement therapy
Description: Liver transplant recipients receiving continuous renal replacement therapy for duration of liver transplant surgery.
Study NCT01619449 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy
Description: Liver transplant recipients receiving continuous renal replacement therapy for duration of liver transplant surgery.
Study NCT00999011 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: once daily mobility activity
Description: in bed and out-of-bed activity including range of motion, chair sitting, sitting at edge of bed without weightbearing, standing, walking.
Study NCT00999011 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: twice daily mobility activity
Description: as with once daily. Goal is to progress intensity and duration of activity over time as patient condition improves for both arms
Study NCT03128060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based palliative care
Description: The HBPC model consists of home visits by an interdisciplinary primary palliative care team (a physician, nurse, social worker, and chaplain). This team provides pain and symptom management, psychosocial support, advance care planning, spiritual counseling, grief counseling, and other services to meet patient and caregiver needs. Within the first week of a patient's enrollment, team members separately visit the patient at home to assess his/her needs as well as the needs of his/her caregiver. Following the patient's initial assessment, subsequent home visits are based on the patient's and caregiver's needs. At a minimum, a core team member visits the patient at home once per week. Additionally, a 24/7 helpline provides access to nurse counseling and after-hours home visits as needed. As a patient's health declines and he/she becomes eligible for hospice care, HBPC clinicians will refer the patient to hospice.
Study NCT03128060 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced usual care
Description: Usual primary care consists of: 1) appointment-based access to primary care providers (PCPs) as requested by the patient; 2) case management services; and 3) provider support through palliative care consultation. These PCPs provide family/internal medicine services as well as access to specialist care. They also offer disease case management and pain and symptom management.~These usual care services are enhanced through training in palliative care provided to PCPs. The training addresses core elements of palliative care, specifically these 6 topics: a palliative care overview; strategies for improving patient-provider communications; instruction in ACP; instruction in managing patients' pain and symptoms; care coordination; and preventing medical crises.
Study NCT01560988 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Borage and Echium Seed Oils
Description: 4.0 g/day borage seed oil and 7.0 g/day echium seed oil. Pills will be taken three times per day for six weeks.
Study NCT01560988 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Corn oil pills
Description: Corn oils pills will be taken three times per day for six weeks.
Study NCT03880409 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2% lidocaine with 1:000,000 epinephrine
Description: 2% lidocaine with 1:000,000 epinephrine is dental local anesthesia
Study NCT01161030 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Almonds
Study NCT01161030 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Almonds
Study NCT02966886 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Eccentric Reaming
Description: Pre-operative CT imaging and surgical planning software based on pre-operative CT scans will be used in each case to determine the degree of eccentric (high side) anterior reaming to within \< 10 degrees of neutral glenoid version.
Study NCT02966886 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Augmented Glenoid Component Implantation
Description: Patients will undergo standard glenoid preparation and implantation of a posteriorly augmented glenoid component. The degree of posterior augment will be based on pre-operative CT scan assessment and templating software with the goal of correcting glenoid retroversion to within 10 degrees of neutral version.
Study NCT02966886 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior Glenoid Bone Grafting
Description: Patient will undergo a total shoulder arthroplasty as per standard technique. Glenoid version will be restored to within 10 degrees of neutral with a posterior glenoid bone graft. The bone graft will be harvested from the humeral head and fixed to the posterior glenoid with mini-fragment screws.
Study NCT03593460 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Synthetic PreImplantation Factor
Description: peptide
Study NCT01697098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone 24 hours
Study NCT01697098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone 12
Study NCT01729585 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Massage Therapy
Description: The Massage Therapy protocol consists of a series of 5 massages administered over 10 (+2) weeks. Length of time for each visit will be approximately 1.5 - 2 hours Typically, a series of treatments over time allows the body time to integrate tissue related changes and potentially maintain a more healthy musculoskeletal state. Based on expert opinion in the field of MT, following a series of massage treatments administered over time, one can anticipate tissue changes. By adding time between treatments, data will describe the ability of subjects to maintain changes over progressively longer periods of time. Treatment protocol will be based on the application of myofascial trigger point therapy (Timberlake, 1999) to musculoskeletal areas of the body often affected by disease progression in CF.
Study NCT03980951 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dural Puncture Epidural Technique
Description: three labor analgesia techniques
Study NCT03980951 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Combined Spinal Epidural without intrathecal opioids
Description: three labor analgesia techniques
Study NCT03980951 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: epidural
Description: three labor analgesia techniques
Study NCT03880409 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 4% articaine with 1:000,000 epinephrine
Description: 4% articaine with 1:000,000 epinephrine is dental local anesthesia
Study NCT00709800 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPT1
Description: IM, 0.1 mg/mL, 2 injections, 0 and 21 days
Study NCT00709800 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPT1
Description: IM, 0.5 mg/mL, 2 injections, 0 and 21 days
Study NCT00709800 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPT1
Description: IM, 1 mg/mL, 2 injections, 0 and 21 days
Study NCT00709800 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VCL-IPM1
Description: IM, 1 mg/mL, 2 injections, 0 and 21 days
Study NCT00709800 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: PBS
Description: IM, 1 mL, 2 injections, 0 and 21 days
Study NCT03563872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Enhancements to team-based care include clinical decision support and improved protocols for telehealth prescribing.
Study NCT03563872 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: Usual, team-based care
Study NCT02657239 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MOVE UP
Description: Weight management behavioral program
Study NCT01944215 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Meal
Description: effect of meal
Study NCT01944215 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: effect of exercise
Study NCT01944215 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Sestamibi
Description: reduce radiation dose
Study NCT00700739 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DISCOVER™ Artificial Cervical Disc
Description: DISCOVER™ Artificial Cervical Disc
Study NCT00700739 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: ACDF
Description: Cervical CFRP I/F CAGE® and SLIM LOC(R) Anterior Cervical Plate System with allograft
Study NCT04863560 — intervention group
Intervention type: OTHER
Intervention: Auditory Cueing
Description: Metronome beat to step in time with
Study NCT01944215 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine Tablet
Description: effect of caffeine
Study NCT01944215 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: External Heating
Description: Heating Pad and warm blanket robe
Study NCT02128568 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Youth Readiness Intervention
Description: The YRI brings together six empirically-supported practice elements shown to be efficacious across different mental health interventions, as well as methods intended to socialize youth and improve self-efficacy. Practice elements address the broad scope of problems evidenced in Sierra Leonean war-affected youth and enhance the YRI's pacing, which progresses through three phases traditionally used in trauma treatments (stabilization, integration, connection). The weekly intervention takes place over 12 sessions lasting approximately one hour and a half. Groups are divided by gender and age. Each group is paired with two interventionists of the same gender.
Study NCT02128568 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth Readiness Intervention
Description: The YRI brings together six empirically-supported practice elements shown to be efficacious across different mental health interventions, as well as methods intended to socialize youth and improve self-efficacy. Practice elements address the broad scope of problems evidenced in Sierra Leonean war-affected youth and enhance the YRI's pacing, which progresses through three phases traditionally used in trauma treatments (stabilization, integration, connection). The weekly intervention takes place over 12 sessions lasting approximately one hour and a half. Groups are divided by gender and age. Each group is paired with two interventionists of the same gender.
Study NCT04125745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CXA-10
Description: Each subject will receive oral CXA-10 at the dose of 300 mg once daily for 12 weeks
Study NCT00887042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine, Busulfan, Thymoglobulin
Description: fludarabine (40 mg/m2 once daily i.v. on days -8, -7, -6, -5, -4 \& -3) busulfan (0.8 mg/kg every 6 hours i.v. on days -6, -5, -4, \& -3) thymoglobulin (2.5 mg/kg once daily i.v. on days -8, -7, \& -6)
Study NCT04135781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab paclitaxel
Description: nab paclitaxel （120mg/m2；iv；d1，8）
Study NCT04135781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegafur
Description: S-1 （\<1.25 m2, 40 mg; 1.25 to ≤1.5 m2, 50 mg; and ≥ 1.5 m2, 60 mg；po；d1-14 bid）